Clinical Trial Update: This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluates BI 754111 alone and in combination with BI 754091 in patients with advanced cancer, testing multiple doses to identify a recommended c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BI-754091
• BI-754111

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED | Results posted: 2026-01-26